Industry experts discuss challenges, trends, and innovations in fluid handling.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
FDA notes progress in drug development, but cites scientific and funding roadblocks.
Cytovance Biologics anticipates continued expansion plans following acquisition by Hepalink USA
Biopharma companies are outsourcing more jobs to cut costs.
Cytovance Biologics Inc. announces development and manufacturing deal with NeuroFx for stem-cell-derived cell-free therapy for strokes.
The Reagan-Udall Foundation for the FDA (RUF) is overcoming initial roadblocks and gaining support from a range of public and private organizations.
Manufacturers seek gradual rollout of more targeted FDA quality metrics program.
Regulatory officials and industry scientists participated in a CMC Strategy Forum sponsored by CASSS in July 2015.